Fedora Pharma

Canadian, early-stage biotech developing beta-lactamase inhibitors as combination therapy for MDR infections (ESKAPE pathogens)

placeEdmonton, Alberta, Canada calendar_todayFounded 2012 groups5 employees language fedorapharma.com

Social engagement

Social engagement: 737 social following, 5 posts in the last 12 months — below the industry typical range.

Recent activity

10 Jun 2026
Leadership hire
Scientific Advisory Board member
9 Apr 2026
Event
ESCMID Global 2026
7 Apr 2026
Event
ESCMID - European Society of Clinical Microbiology and Infectious Diseases Conference
Coming soon